Published May 28, 2019 | Version v1
Journal article Open

REGENERATIVE THERAPIES FOR TREATMENT OF OSTEOARTHRITIS (OA) IN DOGS. REVIEW

Creators

  • 1. University of Forestry, Faculty of Veterinary Medicine, Sofia, Bulgaria

Contributors

  • 1. University of Forestry, Bulgaria

Description

Osteoarthritis is a degenerative joint disease characterized by destructive changes in articular cartilage and formation of new bone tissue - osteophytes. OA is the most common degenerative joint disease in humans and animals. OA affects the entire joint and is characterized by inflammation, remodeling of bones and progressive destruction of constitutive cartilage components.The main purpose in the treatment of osteoarthritis is aimed at relieving pain, maintaining joint mobility, improving the quality of life of the patient, slowing down the development of degenerative changes. Over the last decades, on the basis of a number of studies, the beneficial effects of regenerative medicine in the treatment of injuries in all tissues in the body, in particular, the treatment of osteoarthritis, have been proven. The most commonly used regenerative therapies for the treatment of osteoarthritis are platelet-rich plasma (PRP), bone marrow (BM), and stem cells. These methods are obtained from the patient's own blood or tissues. These therapies have an anti-inflammatory, analgesic, reparative and antidegenerative effect.

Files

vol-4-2_2019-81-85.pdf

Files (85.1 kB)

Name Size Download all
md5:400ed15494a53dce9094d3577074728b
85.1 kB Preview Download

Additional details

Related works

Is documented by
http://scij-tmvm.com/vol./vol.4/2/vol-4-2_2019-81-85.pdf (URL)

References

  • Baltzer A. W., Moser C., Jansen S. A., Krauspe R. (2009). Autologous conditioned сerum (Orthokine) is an effective treatment for knee osteoarthritis. Osteoarthritisand Cartilage, Vol. 17(2): 152– 160.
  • Baxter M. A., Wynn R. F., Jowitt S. N., Wraith J. E., Fairbairn L. J., Bellantuono I. (2004). Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells, Vol. 22(5): 675–82.
  • Black L., Gaynor J., Adams C., Dhupa S., Sams E. (2008). Effect of intra-articular injection of autologous adipose-derived mesenchymal stem and regenerative cells on clinical signs of chronic osteoarthritis of the elbow joint in dogs. Veterinary Therapeutics, Vol. (3): 192–200
  • Cole J., Seroyer T., Bajaj S., Fortier A. (2010). Platelet-rich plasma: where are we now and where are we going? Sports Health: Multidisciplinary Approach, Vol. 3: 203–210.
  • Cook J. L., Anderson C. C., Kreeger J. M., Tomlinson J. L. (2000). Effects of human recombinant interleukin-1beta oncanine articular chondrocytes in three-dimensionalculture. Am J Vet Res, Vol. 61: 766–70.
  • Everts P. A., Hoogbergen M. M., Weber T. A., Devilee R. J., van Monftort G., de Hingh I. H. (2012). Is the use of autologous platelet-rich plasma gels in gynecologic, cardiac, and general, reconstructive surgery beneficial? Curr Pharm Biotechnol, Vol. 13: 1163–72.
  • Filardo G., Kon E., Ruiz P., Vaccaro F., Guitaldi R., Martino D., Cenacchi A., Fornasari M., Marcacci M. (2012). Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single-versus double–spinning approach. Sports Traumatology, Arthroscopy, Vol. 20: 2082–2091.
  • Fortier A., Tuan S. (2012). Stem cells and regenerative therapy. In Tobias M, Johnston (ed.). Veterinary surgery: small animal. Elsevier Saunders, St. Louis 40–42.
  • Fortier L. A., Travis A. J. (2011). Stem cells in veterinary medicine. Stem cell research Therapy, Vol. 1: 9.
  • Frisbie D., Kisiday D., Kawcak C. E., Werpy N. M., McIlwraith C. W. (2009). Evaluation of adipose- derived stromal vascular fraction or bone marrow-derived esenchymal stem cells for treatment of osteoarthritis. Journal of Orthopaedic Research, Vol. 27(12): 1675–1680.
  • Garvican R., German J., Innes F. (2012). Biomarkers in clinical medicine. In Tobias M, Johnston (ed.). Veterinary surgery: small animal. Elsevier Saunders, St. Louis 29–39.
  • Gigante A., Callegari L. (2011). The role of intra–articular hyaluronan (Sinovial ®) in the treatment of osteoarthritis. Rheumatology International, Vol. 31(4): 427–444.
  • Hyer C. F., Berlet G. C., Bussewitz B. W., Hankins T., Ziegler H. L., Philbin T. M. (2013). Quantitative assessment of the yield of osteoblastic connective tissue progenitors in bone marrow aspirate from the iliac crest, tibia, and calcaneus. J Bone Joint Surg Am, Vol. 95(14): 1312–6.
  • Innes, Glayton J., Lascelles D. (2010b). Review of the safety and efficacy of longterm NSAID use in the treatment of canine osteoarthritis. Veterinary Record, Vol. 166 :226–230.
  • Johnston A., McLaughlin M., Budsberg C. (2008). Nonsurgical management of osteoarthritis in dogs. Veterinary Clinics of North America Small Animal Practice, Vol. 38: 1449–1470.
  • Kasten P., Beyen I., Egermann M., Suda A. J., Moghaddam A. A., Zimmermann G., et al. (2008). Instant stem cell therapy: characterization and concentration of human mesenchymal stem cells in vitro. Eur Cell Mater, Vol. 16: 47–55
  • Lee E. H., Hui J. H. P. (2006). The potential of stem cells in orthopaedic surgery. J Bone Joint Surg Br, Vol. 88(7): 841–51.
  • Lee, H. R., Shon, O. J., Park, S. I., Kim, H. J., Kim, S., Ahn, M. W., & Do, S. H. (2016). Platelet– rich plasma increases the levels of catabolic molecules and cellular dedifferentiation in the meniscus of a rabbit model. International Journal of Molecular Sciences, 17(1): 120.
  • Mafi R., Hindocha S., Mafi P., Griffin M., Khan S. (2011). Sources of adult mesenchymal tem cells applicable for musculoskeletal applications–systematic review of the literature. The Open Orthopaedics Journal, Vol. 5: 242–248.
  • Milano G., Sanna Passino E., Deriu L., Careddu G., Manunta L., Manunta A., Saccomanno M., Fabbriciani, C. (2010). The effectof platelet rich plasma combined with microfractures on the treatment of chondral defects: an experimental study in sheep model. Osteoarthritis and Cartilage, Vol. 18(7): 971–980.
  • Mobasheri A., Henrotin Y. (2010). Identification, validation and qualification ofbiomarkers for osteoarthritis in humans and companion animals: missionor the next decade. The Veterinary Journal, Vol. 185: 95–97.
  • Peters A. E., Watts A. E. (2016). Biopsy needle advancement during bone marrow aspiration increases mesenchymal stem cell concentration. Front Vet Sci, Vol. 3:23.
  • R. A. Hauser1, and E. Eteshola. (2013). Rationale for Using Direct Bone Marrow Aspirate as a Proliferant for Regenerative Injection Therapy (Prolotherapy). The Open Open Stem Cell Journal, Vol. 4: 7–14
  • Ross A. Hauser and Amos Orlofsky. (2013). Regenerative Injection Therapy with Whole Bone Marrow Aspirate for Degenerative Joint Disease: A Case Series. Clin Med Insights Arthritis Musculoskelet Disord Vol. 6: 65–72.
  • Sampson S., Reed M., Silvers H., Meng M., Mandelbaum B. (2010). Injection of platelet–rich plasma in patients with primary and secondary knee osteoarthritis: a pilot study. Am J Phys Med Rehabil, Vol. 89: 961–9.
  • Sánchez M., Azofra J., Anitua E., Andía I., Padilla S., Santisteban J., et al. (2003). Plasma rich in growth factors to treat an articular cartilage avulsion: a case report. Med Sci Sports Exerc, Vol. 35: 1648–52.
  • Song L., Tuan R. S. (2004). Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow. FASEB J, Vol. 18(9): 980–2.
  • Spakova T., Rosocha J., Harvanova D., Gharaibeh A. (2012). Treatment of knee joint osteoarthritis with autologous platelet–rich plasma in comparison with hyaluronic acid. American Journal of Physical Medicine Rehabilitation, Vol. 91(5): 411–417
  • Stolzing A., Jones E., McGonagle D., Scutt A. (2008). Age–related changes in human bone marrow– derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev, Vol. 129(3): 163–73.